|
KMID : 0882420090760000010
|
|
Korean Journal of Medicine
2009 Volume.76 No. 0 p.10 ~ p.15
|
|
|
Permanent sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment
|
|
Seo Jeong-Ah
Moon Sung-Soo
Kang Hyoun-Gu
Kim Hyun-Ju
Park Sung-Jae
Lee Youn-Jae
Seol Sang-Yong
|
|
|
Abstract
|
|
|
|
Peginterferon and ribavirin combination therapy for chronic hepatitis C is associated with major adverse effects, and systemic side effects are common. However, little is known about the influence of peginterferon on hearing loss, although it has been described as a rare complication of standard interferon. A 65-year-old man with chronic hepatitis C (genotype 2) developed sudden unilateral right-sided hearing loss just after finishing 24 weeks of treatment with peginterferon α 2a (180 μg/week) and ribavirin (800 mg/day). The audiological examination revealed a right-sided sensorineural hearing loss. Auditory brain-stem response measures confirmed the diagnosis. The hearing loss did not respond to corticosteroid therapy. The auditory disability remained unchanged 12 months after the end of treatment, although no HCV RNA was detectable 24 weeks after the end of treatment. We report a patient who developed irreversible hearing loss just after completing treatment with peginterferon and ribavirin.
|
|
|
KEYWORD
|
|
|
Chronic hepatitis C, Peginterferon, Sudden hearing loss
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|